HERG

From WikiMD's WELLNESSPEDIA

HERG (Human Ether-a-go-go-Related Gene) is a gene that encodes a protein known as Kv11.1, the alpha subunit of a potassium ion channel. This ion channel (sometimes referred to as 'HERG') is best known for its contribution to the electrical activity of the heart that coordinates the heart's beating (cardiac rhythm).

Function[edit]

The HERG gene encodes a protein that is a member of the potassium channel, voltage-gated, subfamily H. This protein is an integral membrane protein and a voltage-gated potassium channel subunit. Mutations in this gene have been associated with hereditary long QT syndrome, also known as an abnormal heart rhythm disorder (arrhythmia).

Clinical significance[edit]

Mutations in HERG can lead to defects in the protein's structure and function, which in turn can cause a decrease in the flow of potassium ions. This can lead to a type of disorder known as Long QT syndrome (LQTS). LQTS from HERG mutations is specifically classified as LQT2. LQT2 is one of the most common forms of inherited LQTS.

Drug-induced Long QT syndrome[edit]

Many drugs, for example some for arrhythmia, antidepressants, antibiotics, and antihistamines, can interfere with the HERG potassium channel, leading to a reduction in the repolarizing current leading to a prolongation of the QT interval and a risk for torsade de pointes.

See also[edit]

References[edit]


External links[edit]

  • WikiMD


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.